Cargando…
Bone morphogenetic protein pathway responses and alterations of osteogenesis in metastatic prostate cancers
BACKGROUND: Prostate cancer is a common cancer in men that annually results in more than 33 000 US deaths. Mortality from prostate cancer is largely from metastatic disease, reflecting on the great strides in the last century of treatments in care for the localized disease. Metastatic castrate resis...
Autores principales: | Provera, Meredith D., Straign, Desiree M., Karimpour, Parvanee, Ihle, Claire L., Owens, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940003/ https://www.ncbi.nlm.nih.gov/pubmed/36054271 http://dx.doi.org/10.1002/cnr2.1707 |
Ejemplares similares
-
Targeting the BMP Pathway in Prostate Cancer Induced Bone Disease
por: Straign, Desiree M., et al.
Publicado: (2021) -
Loss of Myeloid BMPR1a Alters Differentiation and Reduces Mouse Prostate Cancer Growth
por: Ihle, Claire L., et al.
Publicado: (2020) -
Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients
por: Ihle, Claire L., et al.
Publicado: (2019) -
Accelerators of Osteogenesis by Recombinant Human Bone Morphogenetic Protein-2
por: Okubo, Yasunori, et al.
Publicado: (2007) -
FK506 Induces Ligand-Independent Activation of the Bone Morphogenetic Protein Pathway and Osteogenesis
por: Sangadala, Sreedhara, et al.
Publicado: (2019)